Table 4.
Outcomes
| PVE group | PVL group | |
|---|---|---|
| Morbidity/Complication | 3.13 % (95%CI 1.21–5.04) | 5.72 % (95 % CI 0–15.28 %) |
| Length of stay following procedure -days | 2.1 (95 % CI 1–4) | 10.16 (95%CI 6.63–13.69 %) |
| Increase of FLR (%) | 39.75 % (95%CI 30.8–48.6) | 64.65 % (95 % CI 0–136.12 %) |
| Failure of hyperptrophy precluding surgery (%) | 4.8 % (95 % CI 2.07–7.52) | 7.4 % (95 % CI 0–16.12) |
| Time to surgery - days | 37.13 (95 % CI 28.51–45.74) | 53.6 (95%CI 32.14–75.05) |
| Resectability rate (%) | 76.88 % (95 % CI 70.91–82.84) | 63.68 % (95 % CI 56.82–70.54) |
| Disease progression (%) | 17.46 % (95 % CI 11.89–23.02) | 29.29 % (95 % CI 15.69–42.88) |
| Length of stay following liver resection- days | 13.57 (95 % CI 9.8–17.37) | 13 (95 % CI 10.84–15.16) |
| Morbidity following liver resection | 26.58 (95 % CI 19.2–33.95) | 25.37 %(95 % CI 0–53.39) |
| Post resection liver failure | 6.29 % (2.24–10.34) | 14.28 %a |
| Post resection mortality | 2.59 % (95 % CI 1.34–3.83) | – |